12:00 AM
 | 
Oct 15, 2001
 |  BioCentury  |  Strategy

Xenova's clinical pipeline

Xenova's clinical pipeline

Compound Indication Status
XR 9576 Cancer...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >